| Highlights Click here to download the CRO Preferred Program Data Sheet
|
CRO Preferred Program
40 Companies Strong and Growing
A Distinct Advantage
The CRO Preferred Program is designed
specifically for your unique needs.
The program allows you to expand your
service offering to deliver an industry
leading EDC solution to your customers;
over time increasing your revenue stream
and ratio of business won. The following
exclusive features are available to you when you partner with OmniComm.
Fixed Pricing for Phase I - III Trials:
- We provide consistent and predictable pricing
based on the services you need.
- A fixed, preset price for all Phase I, Phase II and
Phase III studies. For terms and conditions for fixed pricing, please request the CRO Preferred
Program pricing sheet.
- No mid-study changes or hidden costs.
- No upfront fees, pay as you go. Most popular
options are included at no additional cost.
Sales and Marketing Support:
- We will provide product demonstrations
and technical support for sales presentations,
upon request.
- Full proposal support is available for
sponsor RFPs.
- Sales support materials will be provided.
- Private branding is available.
- Our marketing support includes joint press
releases and speaking opportunities, website
visibility, and case studies.
Dedicated Hosted Environment:
- We offer a 21CFR Part 11 compliant hosting
environment.
- Production servers located at world-class
Cincinnati Bell Data Center.
- Full web-based access for all CRO and sponsor
participants.
- Study set-up, validation, system administration,
and backup and disaster recovery contingency
services included.
- A study portal will be made available on
Microsoft SharePoint for all study documents.
Training and Support:
- Integrated eLearning and internal training
included.
- Trainers available for onsite meetings.
- Training support provided with comprehensive
printed training materials and documentation.
- 24 x 7 x 365 help desk support included.
Our products and services are designed to support electronic data capture studies, paper – based studies and hybrid trials. Fully validated and compliant with FDA 21CFR part 11, our systems are also compliant with ICH E2B standards, and FDA requirements for drug and device reporting.
Click here to download the CRO Preferred Program Data Sheet
For more information on the
CRO Preferred Program, contact:
Bev Hudson
SVP of Global Business Development
954 473 1254
bhudson@omnicomm.com
|